THC, CBG, and Eye Pressure: Cannabis for Glaucoma Explained

Managing glaucoma requires a careful approach. While the primary goal is to lower intraocular pressure (IOP) to support the health of the optic nerve, the tools used matter, and cannabinoids do not affect everyone the same way. In some cases, certain compounds may negatively impact eye pressure.

By Harrison

If you are considering integrating cannabis into your eye health regimen, it is vital to look at the specific mechanisms of THC, CBG, and the role of CBD.

The Biological Mechanism: How Cannabinoids Affect Eye Pressure

Glaucoma is often characterized by a buildup of aqueous humor, the fluid in the front of the eye. This creates internal pressure that can strain the optic nerve. Because the early stages are often asymptomatic, many people do not realize damage is occurring until they notice peripheral vision loss.

The eyes contain CB1 and CB2 receptors, which play a role in regulating ocular fluid. When specific cannabinoids bind to these receptors, they may help the eye’s drainage system. CB1 receptors, in particular, appear to influence the trabecular meshwork, which can assist in fluid exit and help manage internal pressure.

THC vs. CBG: Choosing the Right Tool

While THC is a well-known cannabinoid regarding IOP, its psychoactive nature may be impractical for daily management. This is where CBG (Cannabigerol) becomes a point of interest.

Feature THC (Tetrahydrocannabinol) CBG (Cannabigerol)
IOP Reduction Potential reduction Potential reduction
Mental Clarity Psychoactive Non-intoxicating
Vascular Support Lowers blood pressure May improve ocular blood flow
Best Use Case Nighttime use Daytime use

CBG is often discussed regarding normal-tension glaucoma. In these cases, pressure may appear within the normal range, but the nerve may still be affected by poor blood flow. CBG may act as a vasodilator, which could support blood vessel dilation to help the optic nerve receive oxygen and nutrients.

The CBD Warning: Why Less Isn't Always More

There is a common misconception that CBD is helpful for all inflammation. For glaucoma patients, CBD may be counterproductive.

Clinical evidence indicates that CBD has the potential to increase intraocular pressure. It may also interfere with the ability of THC to lower pressure. If you are managing glaucoma, read your labels with caution. Avoid "Full Spectrum" products with high CBD ratios. Focus on CBG isolates or specific THC-dominant strains if you choose to experiment with cannabis, and be aware of how CBD intake affects your IOP.

Neuroprotection: Beyond Pressure

Standard prostaglandin eye drops are used to lower pressure, but they do not always provide protection for nerve cells. Cannabinoids may provide supplemental support by acting as antioxidants and helping to modulate glutamate levels. When glutamate levels are too high, they can be toxic to the optic nerve. By helping regulate these levels and supporting retinal ganglion cells, cannabinoids may help preserve sight during periods of fluctuating eye pressure.

Practical Integration and Dosing

A challenge with cannabinoid therapy is the duration of the effect. Many cannabinoids only lower eye pressure for 3 to 4 hours.

advertisement
  • Inhalation: Provides immediate effects but typically wears off in 2–3 hours. It is generally not a long-term strategy for a chronic condition.
  • Edibles/Capsules: Better for overnight management, as they typically last 6–8 hours.
  • Sublingual Oils: Tinctures held under the tongue offer a faster onset than edibles, serving as a middle ground for daytime use.

Research is ongoing regarding cannabinoid-infused eye drops. While they are difficult to formulate because the eye naturally repels oils, they represent a potential future for targeted, non-intoxicating care.

Terpenes: The Supporting Cast

The "entourage effect" suggests that the aromatic compounds (terpenes) in cannabis products change how the body responds. For ocular health, these are notable:

  • Myrcene: May assist in crossing the blood-brain barrier and potentially improves THC absorption.
  • Pinene: May help maintain mental sharpness, potentially countering the "fog" associated with THC.
  • Beta-Caryophyllene: Targets CB2 receptors, which may help lower systemic inflammation.

A Safe Strategy for Patients

Cannabis should not be the first line of defense; it is a supplement to the care provided by your ophthalmologist.

  1. Prioritize standard care: Continue using your prescription drops. Use cannabis only as a supplemental therapy.
  2. Verify the results: Ask your eye doctor to measure your IOP shortly after you have used a specific CBG or THC product to see if it provides any benefit for your physiology.
  3. Watch your blood pressure: THC can lower systemic blood pressure. If it drops too low, it can reduce blood flow to the optic nerve, which could be detrimental.
  4. Avoid CBD: Stay away from high-dose CBD tinctures or gummies.

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

  1. Hepler RS, Frank IR. (1971). Marihuana smoking and intraocular pressure. JAMA. 217(10):1392. PubMed

  2. Colasanti BK, Craig CR, Allara RD. (1984). Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. Exp Eye Res. 39(3):251-9. PubMed

  3. Tomida I, Pertwee RG, Azuara-Blanco A. (2004). Cannabinoids and glaucoma. Br J Ophthalmol. 88(5):708-13. PubMed

  4. Nucci C, Bari M, Spanò A, Corasaniti M, Bagetta G, Maccarrone M, Morrone LA. (2007). Potential roles of (endo)cannabinoids in the treatment of glaucoma: general considerations and future perspectives. Prog Brain Res. 163:657-65. PubMed

advertisement

Ready to find your strain?

Add your strains, pick your effects — we'll rank them.

Open Matchleaf →